10.1038/s42003-024-05903-5 152 SunY.LiQ.GuoH.HeQ
This approach reduces waste from expired preparations while ensuring that patients receive freshly prepared solutions with maximum potency and therapeutic effectiveness
Compounded and microdose GLP-1 medications are not FDA approved, and the FDA does not review them for safety, effectiveness, or quality before marketing
Patient Selection and Considerations: While Semaglutide offers distinct advantages, the selection of a GLP-1 receptor agonist should be personalized based on patient-specific factors, including medical history , treatment goals , and potential side effects
Because it is marketed as a nutritional supplement*, the product does not undergo rigorous testing for safety or quality standards before launch
Biometals 25 , 677686 (2012)